ResMed rises after slight quarterly profit beat

Medical device maker ResMed's RMD.N shares rise 8.1% to $231.81

RMD posted late on Wednesday Q1 adj. profit of $2.37 per share, beating analysts' estimates of $2.36 per share, according to data compiled by LSEG

Company's Q1 revenue rose 8% to $1.29 billion

ResMed said it is "very well positioned" and does not expect the introduction of U.S. tariffs to have a material impact on its financial results

Brokerage William Blair says ResMed products are also exempt from the announced April tariffs, making it "one of the safer stories, if not the safest, from recent headlines"

"We are decreasing our forward EPS estimates modestly, given a challenging macro environment" - Jefferies

As of last close, RMD has risen 1.3% YTD